Ofatumumab, a fully human anti-CD20 monoclonal antibody, has shown superior efficacy and a comparable overall safety profile to teriflunomide in the pivotal ASCLEPIOS I/II trials in people living with relapsing multiple sclerosis (plwRMS). However, data on the efficacy and safety of ofatumumab, a high-efficacy th...
Central nervous system (CNS) autoimmune diseases, including multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), autoimmune encephalitis (AE), and myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD), remain difficult to diagnose, stratify, and treat because clinical phenotypes ov...
It is demonstrated that MIA significantly increases the proportion of NK cells at the maternal-fetal interface, characterized by elevated expression of NKG2D, with this local accumulation persisting until late gestation, highlighting NK cell modulation as a potential therapeutic strategy for maternal infection-associat...
Rongrong Liu, Yuexin Zhao, Xianli Song et al.· Molecular Psychiatry· 0 citations
The clinical patterns of acute attacks and relapses of multiple sclerosis, NMOSD and MOGAD are discussed, including the clinical and para-clinical modalities that are critical for timely recognition and diagnosis, and available evidence regarding treatment selection and responsiveness is presented.
Yu-Jing Li, Wei Jiang, Chao Zhang et al.· Cell Death and Differentiati...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.